Funding Announcement

	Funding Opportunites - Research Further details regarding this announcement can be found at: https://www.alzdiscovery.org/research-and-grants/funding-opportunities/clinical-trials-for-ftd-application-instructions
Sponsor/Award:	ALZHEIMER'S DRUG DISCOVERY FOUNDATION - TREAT FTD FUND - 2019 COMPETITION \| FULL PROPOSAL

Grant Amount:	$500,000-$2,000,000
Deadline:	Dean's: Contact your Faculty Research Office for deadline details. Internal: Feb 08, 2019 Sponsor's: Feb 15, 2019

Subject Areas:
Description:	The Treat FTD Fund is a joint effort by the Alzheimer's Drug Discovery Foundation (ADDF) and the Association for Frontotemporal Degeneration (AFTD) to support clinical development of novel or repurposed drugs for FTD disorders. Running clinical trials in FTD patients will enable investigators to identify optimal approaches to targeting this unique patient population. In addition, trials supported by the Treat FTD Fund will complement efforts such as the FTD Biomarkers Initiative and the Accelerating Drug Discovery for FTD program by employing emergent advances in biomarker development and preclinical research. Funding Priorities include Patient Population, Therapeutic Focus and Clinical Design. Please review the sponsor website for full details.

Application Details:	Your application will be submitted through the ADDF Funding Portal. The submission process involves two steps: Letter of Intent, and invited full application. Invited proposals will be due on February 15, 2019 ADDF FUNDING IS NOT PROVIDED FOR INDIRECT COSTS
NOTE: All Letters of Intent and Full Applications must be processed through Research Development & Services for institutional approval. Requests for Institutional approvals should be received no less than 3 days prior to the posted Sponsor deadline. A ROLA Proposal (bearing applicant, Chair and Dean electronic approvals) is required for each submission.
Western Contacts:

Sponsor Contacts:	1414 Avenue of the Americas Suite 1502 New York, New York, United States